Acorda Therapeutics Inc BAIIA
Quel est le BAIIA de Acorda Therapeutics Inc?
Le BAIIA de Acorda Therapeutics Inc est -$4.08
Quelle est la définition de BAIIA?
Le BAIIA est le bénéfice avant intérêts, impôts, dépréciations et amortissements d’une entreprise. Il s’agit d’une mesure comptable calculée à partir du bénéfice net avant de sustraire les intérêts, impôts et amortissements d’une entreprise, comme mesure de la rentabilité opérationnelle courante de l’entreprise.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
BAIIA des entreprises dans Health Care secteur sur NASDAQ par rapport à Acorda Therapeutics Inc
Que fait Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Entreprises avec baiia similaire à Acorda Therapeutics Inc
- West High Yield (W.H.Y.) Resources a BAIIA de -CAD$4.09
- Proactis Plc a BAIIA de -£4.09
- CareTeQ a BAIIA de -AUD$4.09
- General Moly a BAIIA de -$4.09
- General Moly a BAIIA de -$4.09
- General Moly a BAIIA de -$4.09
- Acorda Therapeutics Inc a BAIIA de -$4.08
- Ahsay Backup Software Development a BAIIA de -HKD$4.08
- Manganese X a BAIIA de -CAD$4.08
- Manganese X Corp a BAIIA de -CAD$4.08
- Mega Uranium a BAIIA de -CAD$4.08
- Krakatoa Resources a BAIIA de -AUD$4.07
- Triumph Gold a BAIIA de -CAD$4.07